SB Satellos Bioscience Inc. Stock: price and insider trades · Canada · SEDISource id SEDI:satellos-bioscience-inc CA · SEDI Mcap CA$286.6M Track the Satellos Bioscience Inc. stock price and the full directors' dealings record of the company, a publicly traded company based in Canada. Shares are quoted on the CA market, under the supervision of SEDI. Market capitalisation: €286.6m. The latest transaction was disclosed on 20 August 2026 (50 - Grant of options). Among the most active insiders: BERGER, FRANKLIN MILAN. The full history is openly available.
Analyst consensus: bullish or bearish? Analysts rate Satellos Bioscience Inc. Buy (bullish), based on 3 analysts. Average price target: CA$17.67.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 20 August 2026
All Executives30 Thresholds0 Prospectus0 Other0
Declarations 30 total
◇ 4 - Director of Issuer · Executives · 18 Aug 2026
10,608 shares @ CA$13.49 0.049% mcap 100.0% of flow Options SEDI:4766684 ◇ 4 - Director of Issuer · Executives · 18 Aug 2026
10,608 shares @ CA$13.49 0.049% mcap 100.0% of flow Options SEDI:4766682 ◇ 4 - Director of Issuer · Executives · 18 Aug 2026
10,608 shares @ CA$13.49 0.049% mcap 100.0% of flow Options SEDI:4766681 ◇ 4 - Director of Issuer · Executives · 18 Aug 2026
10,608 shares @ CA$13.49 0.049% mcap 100.0% of flow Options SEDI:4766680 ◇ 4 - Director of Issuer · Executives · 18 Aug 2026
10,608 shares @ CA$13.49 0.049% mcap 24.4% of flow Options SEDI:4766678 ◇ 4 - Director of Issuer · Executives · 18 Aug 2026
10,608 shares @ CA$13.49 0.049% mcap 100.0% of flow Options SEDI:4766677 ▲ 4 - Director of Issuer · Executives · 13 Jul 2026
2,000 shares @ CA$9.10 0.0069% mcap 4.1% of flow Common Shares SEDI:4752729 Canonical exit: 11 Oct 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 13 Jul 2026
1,000 shares @ CA$9.08 0.0034% mcap 2.0% of flow Common Shares SEDI:4752728 Canonical exit: 11 Oct 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 13 Jul 2026
100 shares @ CA$9.02 0.0003% mcap 0.2% of flow Common Shares SEDI:4752727 Canonical exit: 11 Oct 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 13 Jul 2026
200 shares @ CA$9.01 0.0007% mcap 0.4% of flow Common Shares SEDI:4752726 Canonical exit: 11 Oct 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 13 Jul 2026
100 shares @ CA$8.99 0.0003% mcap 0.2% of flow Common Shares SEDI:4752725 Canonical exit: 11 Oct 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 13 Jul 2026
203 shares @ CA$8.98 0.0007% mcap 0.4% of flow Common Shares SEDI:4752724 Canonical exit: 11 Oct 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 13 Jul 2026
164 shares @ CA$8.94 0.0006% mcap 0.3% of flow Common Shares SEDI:4752723 Canonical exit: 11 Oct 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 13 Jul 2026
1,325 shares @ CA$8.93 0.0045% mcap 2.7% of flow Common Shares SEDI:4752722 Canonical exit: 11 Oct 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 13 Jul 2026
1,001 shares @ CA$8.92 0.0034% mcap 2.0% of flow Common Shares SEDI:4752721 Canonical exit: 11 Oct 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 13 Jul 2026
400 shares @ CA$8.90 0.0013% mcap 0.8% of flow Common Shares SEDI:4752720 Canonical exit: 11 Oct 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 13 Jul 2026
327 shares @ CA$8.89 0.0011% mcap 0.7% of flow Common Shares SEDI:4752719 Canonical exit: 11 Oct 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 13 Jul 2026
3 shares @ CA$8.87 0.0000% mcap 0.0% of flow Common Shares SEDI:4752718 Canonical exit: 11 Oct 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 13 Jul 2026
1 shares @ CA$8.83 0.0000% mcap 0.0% of flow Common Shares SEDI:4752717 Canonical exit: 11 Oct 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 13 Jul 2026
1 shares @ CA$8.82 0.0000% mcap 0.0% of flow Common Shares SEDI:4752716 Canonical exit: 11 Oct 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 14 Jul 2026
2,575 shares @ CA$9.12 0.0089% mcap 5.3% of flow Common Shares SEDI:4752713 Canonical exit: 12 Oct 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 14 Jul 2026
100 shares @ CA$9.09 0.0003% mcap 0.2% of flow Common Shares SEDI:4752712 Canonical exit: 12 Oct 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 14 Jul 2026
100 shares @ CA$9.07 0.0003% mcap 0.2% of flow Common Shares SEDI:4752711 Canonical exit: 12 Oct 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 14 Jul 2026
1,777 shares @ CA$9.03 0.0061% mcap 3.6% of flow Common Shares SEDI:4752709 Canonical exit: 12 Oct 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 14 Jul 2026
300 shares @ CA$9.02 0.0010% mcap 0.6% of flow Common Shares SEDI:4752707 Canonical exit: 12 Oct 2026 (T+90) 25 of 30 declarations
Load more (5 remaining) 关于 Satellos Bioscience Inc. Satellos Bioscience Inc. 是一家专注于开发肌肉疾病疗法的生物技术公司。该公司在多伦多证券交易所 (XTSE) 上市。